IPI-3063 is primarily utilized in the field of oncology research, where it serves as a potent inhibitor targeting specific proteins involved in cancer cell proliferation. Its application is particularly significant in preclinical studies aimed at understanding and disrupting the pathways that contribute to tumor growth and survival. Researchers employ IPI-3063 to investigate its efficacy in halting the progression of various cancers, with a focus on its ability to induce apoptosis in malignant cells. This compound is also explored for its potential to enhance the effectiveness of existing cancer therapies when used in combination treatments. By providing insights into molecular mechanisms, IPI-3063 aids in the development of novel therapeutic strategies for combating resistant and aggressive forms of cancer.